National Pension Service trimmed its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 8.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 298,860 shares of the medical device company’s stock after selling 28,200 shares during the period. National Pension Service owned approximately 0.15% of Cooper Companies worth $27,474,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of the business. State Street Corp increased its holdings in shares of Cooper Companies by 1.2% during the third quarter. State Street Corp now owns 8,590,689 shares of the medical device company’s stock valued at $947,897,000 after purchasing an additional 104,521 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of Cooper Companies by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after purchasing an additional 573,908 shares during the period. Geode Capital Management LLC increased its holdings in shares of Cooper Companies by 1.0% during the third quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company’s stock valued at $527,476,000 after purchasing an additional 48,559 shares during the period. Victory Capital Management Inc. boosted its stake in Cooper Companies by 23.0% during the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after buying an additional 737,726 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Cooper Companies by 11.9% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock valued at $200,665,000 after buying an additional 194,118 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
COO has been the subject of several research reports. Wells Fargo & Company raised their target price on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Morgan Stanley decreased their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Finally, Citigroup decreased their target price on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $117.22.
Cooper Companies Trading Up 0.6 %
NASDAQ:COO opened at $90.38 on Friday. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38. The firm has a market capitalization of $18.04 billion, a price-to-earnings ratio of 46.35, a price-to-earnings-growth ratio of 2.25 and a beta of 1.00. The stock has a fifty day simple moving average of $92.64 and a 200 day simple moving average of $99.53.
Cooper Companies (NASDAQ:COO – Get Free Report) last announced its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.03 billion. During the same period last year, the company posted $0.87 EPS. The business’s quarterly revenue was up 9.8% compared to the same quarter last year. Sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.
Cooper Companies Company Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
See Also
- Five stocks we like better than Cooper Companies
- What Are Dividends? Buy the Best Dividend Stocks
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Best Stocks Under $10.00
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Consumer Discretionary Stocks Explained
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.